This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Designed by European Vaccine Initiative

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

M9  Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies

Course content

Using a combination of theory and hands-on instruction, participants will learn the following:

- Key best practices and methods for vaccine process development from upstream to downstream focusing on a viral vaccine platform.

  • Best practices of cell culturing in single use bioreactors for both adherent and suspension cells;

  • Optimization of filtration and purification technologies;

  • Adjuvant filtration;

- How to integrate vaccine processes in a single use environment;

Minimal requirements

Prior experience with laboratory scale vaccine and/or biologics process development.

Accommodation

Accommodation will be provided. Travel costs are not included.

Course Goals 

Process development and scale-up of viral vaccines.

Timeline 

Application Deadline:  

1 May 2021

Course Dates:

Q3 2021  (2 days)

Contact 

Anissa Boumlic anissa.boumlic@merckgroup.com

Maria Lawrenz maria.lawrenz@vformulation.org